Humana (HUM): Shares jump as 2027 star ratings improve sharply

By Centiview Research•Published 12 Oct 2026, 08:16 UTC•1 min read

Humana rose about 15% on Oct 9 after CMS's 2027 Medicare Advantage star ratings. Humana says about 95% of members are in plans rated 4 stars or higher, far above analyst expectations of 60-70%. Ratings drive 2028 bonus payments.

Sources

For information only. Not financial advice. See our disclaimer and editorial standards. Spotted an error? Tell us.

Related takes

Humana (HUM): Largest Medicare Advantage contract wins back 4 stars

Humana's largest Medicare Advantage contract rose back above the 4-star bonus cutoff in CMS's 2027 ratings. TD Cowen estimates $3bn+ of extra 2028…

Centiview • 11 Oct 2026Healthcare

Viatris (VTRS): Agrees to buy Pacira BioSciences for $1.65 billion in cash

Viatris agreed to buy Pacira for $36.50 a share in cash, about $1.65B, adding non-opioid pain drugs Exparel and Zilretta. Pacira jumped roughly 44%…

Centiview • 13 Oct 2026Healthcare

Bristol Myers Squibb (BMY): Pulmonary fibrosis drug admilparant hits Phase 3 goal at 60 mg

Bristol Myers said admilparant met the primary goal in its Phase 3 ALOFT-IPF trial at 60 mg, but the 120 mg dose slowed lung decline without a…

Centiview • 12 Oct 2026Healthcare